[ad_1]
British Health Minister Matt Hancock conducted evaluations on the Oxford-AstraZeneca vaccine, which was approved by the Medicines and Healthcare Products Regulatory Board (MHRA), and the increase in cases of Kovid-19 in the country.
Announcing that the Oxford-AstraZeneca vaccine will begin production on Monday, January 4, Hancock said: “With this, widespread vaccination will accelerate even more. It ushers in the day when we will return our lives to normal. This morning, we can see the way out of the epidemic. Vaccines are the only way to get rid of the epidemic. ” used the expression.
Hancock emphasized that the storage and transport conditions of the Oxford-AstraZeneca Kovid-19 vaccine are more suitable than the vaccine developed by Pfizer and BioNTech, which began to be rolled out in the country on December 8.
“NUMBERS OF CASE PRESSURES IN THE NATIONAL HEALTH SERVICE”
Noting that the majority of Kovid-19 cases seen in the UK in recent days are caused by a species spreading 70 percent faster, Hancock said the number of cases reached severe levels in December. and that this puts pressure on the National Health Service (NHS).
class = “cf”>
Hancock noted that with the appearance of a strain of Kovid-19, it became more difficult to stop the spread of the virus, but with the approval of the widespread use of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines, they reached an important stage in the fight against the epidemic.
COVID-19 VACCINATED THE SECOND APPROVED IN THE COUNTRY
The UK Medicines and Health Products Regulatory Authority announced that the Kovid-19 vaccine developed by the University of Oxford in cooperation with the British-Swedish pharmaceutical company AstraZenaca was safe and approved for widespread use in the country.
Thus, after the vaccine developed by the German biotechnology company BioNTech with the American pharmaceutical company Pfizer, the 2nd Kovid-19 vaccine was registered.
MHRA previously approved the widespread use of the Biontech-Pfizer vaccine on December 2. The vaccine was “the first Kovid-19 vaccine registered by health institutions in the world.”
